161 related articles for article (PubMed ID: 36942949)
1. Avoiding unnecessary ventricular pacing is associated with reduced incidence of heart failure hospitalizations and persistent atrial fibrillation in pacemaker patients.
Arnold M; Richards M; D'Onofrio A; Faulknier B; Gulizia M; Thakur R; Sakata Y; Lin W; Pollastrelli A; Grammatico A; Auricchio A; Boriani G
Europace; 2023 May; 25(5):. PubMed ID: 36942949
[TBL] [Abstract][Full Text] [Related]
2. Reduction of unnecessary right ventricular pacing by managed ventricular pacing and search AV+ algorithms in pacemaker patients: 12-month follow-up results of a randomized study.
Chen S; Chen K; Tao Q; Zheng L; Shen F; Wu S; Fan J; Xu G; Wang L; Zhou X; Zhang S;
Europace; 2014 Nov; 16(11):1595-602. PubMed ID: 24706091
[TBL] [Abstract][Full Text] [Related]
3. The PhysioVP-AF study, a randomized controlled trial to assess the clinical benefit of physiological ventricular pacing vs. managed ventricular pacing for persistent atrial fibrillation prevention in patients with prolonged atrioventricular conduction: design and rationale.
Pastore G; Bertini M; Bonanno C; Coluccia G; Dell'Era G; De Mattia L; Grieco D; Katsouras G; Maines M; Marcantoni L; Marinaccio L; Paglino G; Palmisano P; Ziacchi M; Zoppo F; Noventa F
Europace; 2023 May; 25(5):. PubMed ID: 36974970
[TBL] [Abstract][Full Text] [Related]
4. Reduction of right ventricular pacing in patients with sinus node dysfunction through programming a long atrioventricular delay along with the DDIR mode.
Nitardy A; Langreck H; Dietz R; Stockburger M
Clin Res Cardiol; 2009 Jan; 98(1):25-32. PubMed ID: 18853096
[TBL] [Abstract][Full Text] [Related]
5. Cardiac pacing strategies and post-implantation risk of atrial fibrillation and heart failure events in sinus node dysfunction patients: a collaborative analysis of over 6000 patients.
Chen S; Wang Z; Kiuchi MG; Andrea BR; Krucoff MW; Liu S; Pürerfellner H
Clin Res Cardiol; 2016 Aug; 105(8):687-698. PubMed ID: 26913516
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical effects of ventricular pacing reduction with a changeover mode to minimize ventricular pacing in a general pacemaker population.
Stockburger M; Boveda S; Moreno J; Da Costa A; Hatala R; Brachmann J; Butter C; Garcia Seara J; Rolando M; Defaye P
Eur Heart J; 2015 Jan; 36(3):151-7. PubMed ID: 25179761
[TBL] [Abstract][Full Text] [Related]
7. A comparison of AAIR versus DDDR pacing for patients with sinus node dysfunction: a long-term follow-up study.
Mutagaywa RK; Tumaini B; Chin A
Cardiovasc J Afr; 2021 Jan-Feb 23; 32(1):17-20. PubMed ID: 32946543
[TBL] [Abstract][Full Text] [Related]
8. Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial.
Boriani G; Pieragnoli P; Botto GL; Puererfellner H; Mont L; Ziacchi M; Manolis AS; Gulizia M; Tukkie R; Landolina M; Ricciardi G; Cicconelli M; Grammatico A; Biffi M
Europace; 2019 Apr; 21(4):636-644. PubMed ID: 30649270
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of persistent atrial fibrillation during pacing for sinus node disease: The influence of His bundle pacing versus managed ventricular pacing.
Pastore G; Marcantoni L; Lanza D; Maines M; Noventa F; Corbucci G; Rigatelli G; Baracca E; Roncon L; Zanon F
J Cardiovasc Electrophysiol; 2021 Jan; 32(1):110-116. PubMed ID: 33179400
[TBL] [Abstract][Full Text] [Related]
10. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease.
Sweeney MO; Bank AJ; Nsah E; Koullick M; Zeng QC; Hettrick D; Sheldon T; Lamas GA;
N Engl J Med; 2007 Sep; 357(10):1000-8. PubMed ID: 17804844
[TBL] [Abstract][Full Text] [Related]
11. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study.
Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN
Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945
[TBL] [Abstract][Full Text] [Related]
12. Pacing mode survival in patients with single chamber atrial pacemaker for sinus node dysfunction.
Velayuthan R; Sukumar SK; Bootla D; Balaguru S; Anantharaj A; Satheesh S; Selvaraj RJ
Indian Heart J; 2024; 76(1):27-30. PubMed ID: 38070672
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficiency of ventricular pacing prevention with an AAI-DDD changeover mode in patients with sinus node disease or atrioventricular block: impact on battery longevity-a sub-study of the ANSWER trial.
Stockburger M; Defaye P; Boveda S; Stancak B; Lazarus A; Sipötz J; Nardi S; Rolando M; Moreno J
Europace; 2016 May; 18(5):739-46. PubMed ID: 26612882
[TBL] [Abstract][Full Text] [Related]
14. Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block.
Gillis AM; Pürerfellner H; Israel CW; Sunthorn H; Kacet S; Anelli-Monti M; Tang F; Young M; Boriani G;
Pacing Clin Electrophysiol; 2006 Jul; 29(7):697-705. PubMed ID: 16884504
[TBL] [Abstract][Full Text] [Related]
15. Dual-chamber pacemakers for treating symptomatic bradycardia due to sick sinus syndrome without atrioventricular block: a systematic review and economic evaluation.
Edwards SJ; Karner C; Trevor N; Wakefield V; Salih F
Health Technol Assess; 2015 Aug; 19(65):1-210. PubMed ID: 26293406
[TBL] [Abstract][Full Text] [Related]
16. The OPTI-MIND study: a prospective, observational study of pacemaker patients according to pacing modality and primary indications.
Biffi M; Melissano D; Rossi P; Kaliska G; Havliĉek A; Pelargonio G; Romero R; Guastaferro C; Menichelli M; Vireca E; Frisoni J; Boriani G; Malacky T
Europace; 2014 May; 16(5):689-97. PubMed ID: 24500787
[TBL] [Abstract][Full Text] [Related]
17. Natural history of sinus node disease treated with atrial pacing in 213 patients: implications for selection of stimulation mode.
Brandt J; Anderson H; Fåhraeus T; Schüller H
J Am Coll Cardiol; 1992 Sep; 20(3):633-9. PubMed ID: 1512343
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome.
Andersen HR; Nielsen JC; Thomsen PE; Thuesen L; Mortensen PT; Vesterlund T; Pedersen AK
Lancet; 1997 Oct; 350(9086):1210-6. PubMed ID: 9652562
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of AAIR pacing in selected patients with sick sinus syndrome.
Senaratne J; Herath TT; Beaudette D; Irwin M; Gulamhusein S; Senaratne MP
Medicine (Baltimore); 2018 Oct; 97(42):e12833. PubMed ID: 30334983
[TBL] [Abstract][Full Text] [Related]
20. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.
Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G;
Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
